piroximone

Known as: 4-ethyl-1,3-dihydro-5-(4-pyridinylcarbonyl)-2H-imidazol-2-one 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1984-2011
024619842011

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1994
1994
This study was undertaken to assess the haemodynamic effects of the combined infusion of prostacyclin and piroximone, a… (More)
Is this relevant?
1993
1993
1. The isolated circulatory response to intravenous application of the phosphodiesterase (PDE) inhibitors piroximone and… (More)
Is this relevant?
1988
1988
Phosphodiesterase isozymes were isolated by diethylaminoethyl ether (DEAE) column chromatography from cardiac muscle (canine… (More)
Is this relevant?
1987
1987
Several novel cardiotonic vasodilators including bipyridines (amrinone and milrinone), imidazolones (enoximone and piroximone… (More)
Is this relevant?
1987
1987
To assess the potential utility of piroximone (MDL-19,205), an investigational inotrope-vasodilator agent, in severe heart… (More)
Is this relevant?
1987
1987
The hemodynamic and clinical response to oral and intravenous piroximone was examined in 25 patients with chronic cardiac failure… (More)
Is this relevant?
1986
1986
Piroximone (MDL 19,205), a new phosphodiesterase inhibitor with positive inotropic and vasodilating properties, was administered… (More)
Is this relevant?
1986
1986
Six healthy, male subjects received single intravenous and oral doses of piroximone. Plasma piroximone concentrations were… (More)
  • table 1
Is this relevant?
1985
1985
The effects of milrinone and piroximone were compared to those of isoprenaline, dibutyryl adenosine 3':5'-cyclic monophosphate… (More)
Is this relevant?
1985
1985
The mechanism of the inotropic effect of piroximone HCl [MDL 19205A, 4-ethyl-1,3-dihydro-5-(4-pyridinylcarbonyl)-2H-imidozol-2-on… (More)
Is this relevant?